Abstract
The success of clinical trials in Huntington disease (HD) will depend to a large degree on the quality of the outcome measures. Using data from the TRACK-HD study, a recent publication proposes a battery of assessments that could be used as outcomes in future clinical trials in patients with early HD. © 2012 Macmillan Publishers Limited. All rights reserved.
Cite
CITATION STYLE
APA
Paulsen, J. S., & Long, J. D. (2012, May). Neurodegenerative disease: Establishing a clinical trial battery for Huntington disease. Nature Reviews Neurology. https://doi.org/10.1038/nrneurol.2012.67
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free